Kenvue's improvements in marketing and management could drive future growth. Read why there is potential for a turnaround for ...

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger ...

Hedge fund Starboard Value has nominated four directors, including its chief investment officer, to the board of consumer ...

Operator Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. [Operator instructions] ...

The company forecast flat to 2% growth in 2025 per share adjusted profit, compared with $1.14 it earned in 2024. Analysts ...

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...

Shares of Kenvue Inc. KVUE slipped 4.53% to $19.80 Thursday, on what proved to be an all-around mixed trading session for the ...

Aid, reported sales that missed analyst estimates after weaker-than-expected volumes hurt results. The key measure of organic ...

In a report released today, Lauren Lieberman from Barclays maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report), with a price ...

Bas Vorsteveld will oversee Kenvue’s Northern Europe business in the UK, Ireland, Norway, Sweden, Denmark and Finland, across a portfolio of iconic brands including Nicorette®**, Aveeno®, Johnson’s® ...

Kenvue shows decent growth but struggles with profitability. Find out why KVUE stock is a 'hold' as cost-cutting efforts face ...